CCN(CC)CCO/N=C1\CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@]12C.Cl
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?